Ineffectiveness of high‐dose methotrexate for prevention of CNS relapse in diffuse large B ‐cell lymphoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Ineffectiveness of high‐dose methotrexate for prevention of CNS relapse in diffuse large B ‐cell lymphoma

Published:2021-04-20 Issue:7 Volume:96 Page:764-771
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am J Hematol

Author:

Puckrin Robert¹^ORCID,El Darsa Haidar²,Ghosh Sunita³,Peters Anthea⁴,Owen Carolyn⁵,Stewart Douglas⁵

Affiliation:

1. Postgraduate Medical Education University of Calgary Calgary Alberta Canada

2. Postgraduate Medical Education University of Alberta Edmonton Alberta Canada

3. Alberta Health Services Cancer Control Alberta Edmonton Alberta Canada

4. University of Alberta and Cancer Cross Institute Edmonton Alberta Canada

5. University of Calgary and Tom Baker Cancer Centre Calgary Alberta Canada

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.26181

Reference30 articles.

1. CNS events in elderly patients with aggressive lymphoma treated with modern chemotherapy (CHOP-14) with or without rituximab: an analysis of patients treated in the RICOVER-60 trial of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL)

2. Influence of Rituximab on Central Nervous System Relapse in Diffuse Large B-Cell Lymphoma and Role of Prophylaxis—A Systematic Review of Prospective Studies

3. Central nervous system involvement following diagnosis ofnon-Hodgkin’s lymphoma: a risk model

4. Secondary CNS relapse in diffuse large B-cell lymphoma: defining high-risk patients and optimization of prophylaxis strategies

5. Prognostic factors in 140 adult patients with non-Hodgkin's lymphoma with systemic central nervous system (CNS) involvement. A single centre analysis

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification, risk factors, and clinical course of CNS relapse in DLBCL patients across 19 prospective phase 2 and 3 trials—a LYSA and GLA/ DSHNHL collaboration;Leukemia;2024-08-16

2. Central nervous system prophylaxis in large B‐cell lymphoma: A British Society for Haematology Good Practice Paper;British Journal of Haematology;2024-08-11

3. Rechallenge With High-Dose Methotrexate After Treatment With Glucarpidase in Adult Patients With Lymphoma;JCO Oncology Practice;2024-06

4. Liquid biopsy for improving diagnosis and monitoring of CNS lymphomas: A RANO review;Neuro-Oncology;2024-04-10

5. IELSG30 phase 2 trial: intravenous and intrathecal CNS prophylaxis in primary testicular diffuse large B-cell lymphoma;Blood Advances;2024-03-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3